These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18346896)

  • 1. Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide.
    Vasdev N; LaRonde FJ; Woodgett JR; Garcia A; Rubie EA; Meyer JH; Houle S; Wilson AA
    Bioorg Med Chem; 2008 May; 16(9):5277-84. PubMed ID: 18346896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.
    Collins I; Caldwell J; Fonseca T; Donald A; Bavetsias V; Hunter LJ; Garrett MD; Rowlands MG; Aherne GW; Davies TG; Berdini V; Woodhead SJ; Davis D; Seavers LC; Wyatt PG; Workman P; McDonald E
    Bioorg Med Chem; 2006 Feb; 14(4):1255-73. PubMed ID: 16249095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca
    Fusi F; Trezza A; Spiga O; Sgaragli G; Bova S
    Biochem Pharmacol; 2017 Sep; 140():53-63. PubMed ID: 28583845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of potent protein kinase inhibitors using the bisubstrate approach.
    Ricouart A; Gesquiere JC; Tartar A; Sergheraert C
    J Med Chem; 1991 Jan; 34(1):73-8. PubMed ID: 1992155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of c-fos mRNA by the protein kinase A inhibitor N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide.
    Huang YT; Lin JK; Lee MT
    Biochem Pharmacol; 1999 Nov; 58(10):1639-47. PubMed ID: 10535756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.
    Xu R; Banka A; Blake JF; Mitchell IS; Wallace EM; Bencsik JR; Kallan NC; Spencer KL; Gloor SL; Martinson M; Risom T; Gross SD; Morales TH; Wu WI; Vigers GP; Brandhuber BJ; Skelton NJ
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2335-40. PubMed ID: 21420856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase.
    Grunewald GL; Seim MR; Regier RC; Martin JL; Gee CL; Drinkwater N; Criscione KR
    J Med Chem; 2006 Sep; 49(18):5424-33. PubMed ID: 16942016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-89, a non-specific inhibitor of protein kinase A, promotes post-ischemic cardiac contractile recovery and reduces infarct size.
    Makaula S; Lochner A; Genade S; Sack MN; Awan MM; Opie LH
    J Cardiovasc Pharmacol; 2005 Apr; 45(4):341-7. PubMed ID: 15772523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cytotoxic T lymphocyte-mediated lysis and cellular proliferation by isoquinoline sulfonamide protein kinase inhibitors. Evidence for the involvement of protein kinase C in lymphocyte function.
    Juszczak RJ; Russell JH
    J Biol Chem; 1989 Jan; 264(2):810-5. PubMed ID: 2783420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition.
    Inoue H; Hase K; Segawa A; Takita T
    Eur J Pharmacol; 2013 Aug; 714(1-3):170-7. PubMed ID: 23810683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of PKA to the excitatory mechanism of adenosine in guinea pig superior colliculus slices.
    Hirai H; Ikeuchi Y; Okada Y
    Neurosci Lett; 1994 Nov; 182(1):33-6. PubMed ID: 7891883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors.
    Xu RM; Carmel G; Kuret J; Cheng X
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6308-13. PubMed ID: 8692811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugging the Undruggable: How Isoquinolines and PKA Initiated the Era of Designed Protein Kinase Inhibitor Therapeutics.
    Lorenz R; Wu J; Herberg FW; Taylor SS; Engh RA
    Biochemistry; 2021 Nov; 60(46):3470-3484. PubMed ID: 34370450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of [(11)C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β).
    Cole EL; Shao X; Sherman P; Quesada C; Fawaz MV; Desmond TJ; Scott PJ
    Nucl Med Biol; 2014 Jul; 41(6):507-12. PubMed ID: 24768148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.
    Zajdel P; Marciniec K; Maślankiewicz A; Satała G; Duszyńska B; Bojarski AJ; Partyka A; Jastrzębska-Więsek M; Wróbel D; Wesołowska A; Pawłowski M
    Bioorg Med Chem; 2012 Feb; 20(4):1545-56. PubMed ID: 22277589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors.
    Malmström J; Viklund J; Slivo C; Costa A; Maudet M; Sandelin C; Hiller G; Olsson LL; Aagaard A; Geschwindner S; Xue Y; Vasänge M
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5919-23. PubMed ID: 22889803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone secretion by luteinizing human granulosa cells: a possible cAMP-dependent but PKA-independent mechanism involved in its regulation.
    Chin EC; Abayasekara DR
    J Endocrinol; 2004 Oct; 183(1):51-60. PubMed ID: 15525573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity.
    Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
    J Biol Chem; 1996 Oct; 271(42):26157-64. PubMed ID: 8824261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
    Chijiwa T; Mishima A; Hagiwara M; Sano M; Hayashi K; Inoue T; Naito K; Toshioka T; Hidaka H
    J Biol Chem; 1990 Mar; 265(9):5267-72. PubMed ID: 2156866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors.
    Zajdel P; Marciniec K; Maślankiewicz A; Grychowska K; Satała G; Duszyńska B; Lenda T; Siwek A; Nowak G; Partyka A; Wróbel D; Jastrzębska-Więsek M; Bojarski AJ; Wesołowska A; Pawłowski M
    Eur J Med Chem; 2013 Feb; 60():42-50. PubMed ID: 23279866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.